I tend to agree more consistent news glow on trials progress would be helpful and not waiting for big conferences.
Based on reports, I underestand more news is coming by the end of this month and that will hopefully makes things clear as to what results have been, not just re AIPAC, and also hopefully before the end of the year we will have news re direction from here re AIPAC phase III (which i believe is immenant) and maybe we get some news as to how it may be funded. Based on my educated guess, it is highly likely a lot of planning had already started before SITC as most of data was reasonably known. So, hopefully some news of partnership will be in there too.
Fingers crossed. AIMO, DYOR.
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-20
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.015(4.35%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $787.9K | 2.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 261805 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 204415 | 16 |
View Market Depth
| Last trade - 15.34pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |